Prenatal screening and diagnosis are often used interchangeably, confusing both patients and physicians on the actual meaning of these two very different genetic testing options. This uncertainty has caused a growing concern in pregnant patients and a desire for greater clarity in their genetic screening options. Join host Dr. Lisa Mazzullo, assistant professor of OB-GYN at Northwestern University's Feinberg School of Medicine and her guest, Director of the Reproductive Genetics Department and Distinguished Physician at Northwestern Memorial Hospital, Lee Shulman, MD, as they review the difference between screening and diagnosis in addition to discussing the newest and most accurate forms of prenatal genetic testing options.
Prenatal Screening vs. Prenatal Diagnosis
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Prenatal screening and diagnosis are often used interchangeably, confusing both patients and physicians on the actual meaning of these two very different genetic testing options. This uncertainty has caused a growing concern in pregnant patients and a desire for greater clarity in their genetic screening options. Join host Dr. Lisa Mazzullo, assistant professor of OB-GYN at Northwestern University's Feinberg School of Medicine and her guest, Director of the Reproductive Genetics Department and Distinguished Physician at Northwestern Memorial Hospital, Lee Shulman, MD, as they review the difference between screening and diagnosis in addition to discussing the newest and most accurate forms of prenatal genetic testing options.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Level Up Your Skills: Tailoring Management of HF
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?